257 related articles for article (PubMed ID: 22183794)
1. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
He T; Chen L; Chen Y; Han Y; Yang WQ; Jin MW
Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
[TBL] [Abstract][Full Text] [Related]
2. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
3. 3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats.
Mao Z; Liang Y; Du X; Sun Z
Can J Physiol Pharmacol; 2009 Sep; 87(9):720-8. PubMed ID: 19794523
[TBL] [Abstract][Full Text] [Related]
4. The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1.
Fan M; Song J; He Y; Shen X; Li J; Que L; Zhu G; Zhu Q; Cai X; Ha T; Chen Q; Xu Y; Li C; Li Y
Biochim Biophys Acta; 2016 Jun; 1862(6):1191-202. PubMed ID: 26964796
[TBL] [Abstract][Full Text] [Related]
5. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
6. Fish oil constituent eicosapentaenoic acid inhibits endothelin-induced cardiomyocyte hypertrophy via PPAR-α.
Shimojo N; Jesmin S; Sakai S; Maeda S; Miyauchi T; Mizutani T; Aonuma K; Kawano S
Life Sci; 2014 Nov; 118(2):173-8. PubMed ID: 24792520
[TBL] [Abstract][Full Text] [Related]
7. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
Song YH; Cai H; Gu N; Qian CF; Cao SP; Zhao ZM
J Pharm Pharmacol; 2011 Apr; 63(4):541-9. PubMed ID: 21401606
[TBL] [Abstract][Full Text] [Related]
8. Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model.
Zhang Y; Liao P; Zhu M; Li W; Hu D; Guan S; Chen L
Cell Physiol Biochem; 2017; 41(3):849-864. PubMed ID: 28214892
[TBL] [Abstract][Full Text] [Related]
9. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
10. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
11. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
12. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
14. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
[TBL] [Abstract][Full Text] [Related]
15. [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
Sheng L; Ye P; Liu YX
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1080-4. PubMed ID: 16563274
[TBL] [Abstract][Full Text] [Related]
16. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
17. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
18. Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats.
Maki T; Kawahara Y; Tanonaka K; Yagi A; Takeo S
Planta Med; 2002 Dec; 68(12):1103-7. PubMed ID: 12494338
[TBL] [Abstract][Full Text] [Related]
19. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
